Heffernan Michael Thomas
SEC CIK 1448914 · EDGAR
BoughtSold
Most active insiders at TRVI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Heffernan Michael Thomas | Dir | — | $595.8K |
| 2 | Galletta Christopher | See Remarks | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-17 16:55 | 2026-09-15 | TRVI | Trevi Therapeutics, Inc. | Heffernan Michael Thomas | Dir | M - OptEx | $3.19 | +39.5K | 27.4K | New | +$126.1K |
| DMT | 2026-09-17 16:55 | 2026-09-15 | TRVI | Trevi Therapeutics, Inc. | Heffernan Michael Thomas | Dir | S - Sale+OE | $15.09 | -39.5K | 6,351 | -86% | -$595.8K |
| 2025-02-12 | 2025-02-10 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Heffernan Michael Thomas | Dir | A - Grant | $0.00 | +4,820 | 50.3K | +11% | $0 | |
| 2024-05-16 | 2024-05-16 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Heffernan Michael Thomas | Dir | A - Grant | $0.00 | +7,693 | 45.5K | +20% | $0 | |
| 2023-05-19 | 2023-05-18 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Heffernan Michael Thomas | Dir | A - Grant | $0.00 | +9,792 | 37.8K | +35% | $0 | |
| DM | 2022-12-27 | 2022-12-22+ | COLL | COLLEGIUM PHARMACEUTICAL, INC | Heffernan Michael Thomas | Dir | M - OptEx | $16.15 | +25.0K | 28.3K | +778% | +$404.4K |
| DM | 2022-12-27 | 2022-12-22+ | COLL | COLLEGIUM PHARMACEUTICAL, INC | Heffernan Michael Thomas | Dir | S - Sale+OE | $23.58 | -25.0K | 28.0K | -47% | -$590.5K |
| DM | 2022-12-21 | 2022-12-19+ | COLL | COLLEGIUM PHARMACEUTICAL, INC | Heffernan Michael Thomas | Dir | S - Sale+OE | $23.09 | -84.0K | 28.0K | -75% | -$1.94M |
| DM | 2022-12-21 | 2022-12-19+ | COLL | COLLEGIUM PHARMACEUTICAL, INC | Heffernan Michael Thomas | Dir | M - OptEx | $16.15 | +84.0K | 74.6K | New | +$1.36M |
| DM | 2022-12-14 | 2022-12-12+ | COLL | COLLEGIUM PHARMACEUTICAL, INC | Heffernan Michael Thomas | Dir | S - Sale+OE | $22.14 | -189.6K | 28.0K | -87% | -$4.20M |
| DM | 2022-12-14 | 2022-12-12+ | COLL | COLLEGIUM PHARMACEUTICAL, INC | Heffernan Michael Thomas | Dir | M - OptEx | $15.10 | +189.6K | 189.7K | +184,084% | +$2.86M |
| A | 2022-10-12 | 2022-10-03 | BHVN | Biohaven Ltd. | Heffernan Michael Thomas | Dir | F - Tax | $7.50 | -9,699 | 15.2K | -39% | -$72.7K |
| DM | 2022-10-05 | 2022-10-03 | BHVN | Biohaven Ltd. | Heffernan Michael Thomas | Dir | M - OptEx | $3.13 | +23.2K | 24.9K | +1,399% | +$72.7K |
| D | 2022-10-05 | 2022-10-03 | BHVN | Biohaven Ltd. | Heffernan Michael Thomas | Dir | F - Tax | $7.50 | -5,507 | 19.4K | -22% | -$41.3K |
| D | 2022-10-05 | 2022-10-03 | BHVN | Biohaven Ltd. | Heffernan Michael Thomas | Dir | J - Other | $0.00 | +1,660 | 1,660 | New | $0 |
| 2022-05-23 | 2022-05-19 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Heffernan Michael Thomas | Dir | A - Grant | $0.00 | +14.0K | 28.0K | +100% | $0 |
Purchase Sale Sale after option exercise All abbreviations